Desmopressin intranasal - CPX Pharmaceuticals/Serenity Pharmaceuticals

Drug Profile

Desmopressin intranasal - CPX Pharmaceuticals/Serenity Pharmaceuticals

Alternative Names: AV002 - Avadel Pharmaceuticals; Desmopressin acetate; Intranasal desmopressin - Serenity Pharmaceuticals; Noctiva; SER 120; SER-120 - CPX Pharmaceuticals/Serenity Pharmaceuticals

Latest Information Update: 03 May 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CPEX Pharmaceuticals; Serenity Pharmaceuticals Corporation
  • Developer Serenity Pharmaceuticals Corporation
  • Class Antidiuretics; Antihaemorrhagics; Hormones; Urologics; Vasoconstrictors; Vasopressins
  • Mechanism of Action Vasopressin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Nocturia

Most Recent Events

  • 01 May 2018 Launched for Nocturia (In the elderly) in USA (Intranasal)
  • 01 May 2018 Launched for Nocturia in USA (Intranasal)
  • 05 Oct 2017 Avadel Pharmaceuticals intends to launch desmopressin intranasal in the second quarter of 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top